The Norwegian life sciences landscape is currently undergoing a systemic transition, evolving from a research-intensive academic environment into a globally integrated commercial powerhouse. This metamorphosis is facilitated by a unique confluence of high-trust public health data, a robust sovereign wealth environment and a maturing infrastructure of specialised clusters such as Norway Health Tech, the Oslo Cancer Cluster and Aleap. As the global healthcare market increasingl

The announcement on March 9th, 2026, at the HIMSS26 conference in Dallas, Texas, regarding the strategic partnership between Samsung Electronics America and Verily Life Sciences represents a definitive shift in the landscape of clinical research and population health management. By systematically bridging Samsung’s Galaxy Watch8 hardware with Verily’s Pre platform, the collaboration aims to replace the traditional, episodic model of clinical data collection with a continuous,